Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-22-084772

Director acquired 32,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SCHADE CHRISTIAN S Director 2022-07-28 Grant or award +32,400 259,246 D
Derivatives
SCHADE CHRISTIAN S Director 2022-07-28 Grant or award · Stock Option (right to Buy) +47,600 47,600 D
Loading xslF345X03/tm2222147-9_4seq1.xml…